Evidence of injury caused by gas bubbles in a live marine mammal: barotrauma in a California sea lion Zalophus californianus
WV Bonn(Marine Mammal Center), Frances M. D. Gulland(Marine Mammal Center), Sophie Dennison(Marine Mammal Center), Denise J. Greig(Marine Mammal Center), Peter F. Cook(University of California, Santa Cruz), Jerome Barakos(Sutter Health), Eric W. Montie(University of South Carolina Beaufort), K Colegrove(University of California, Davis), Nicola Pussini(Marine Mammal Center)
Cited by 17
Related Papers
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
|Neurology|2009|741
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
|The Lancet Neurology|2010|696
Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
|JAMA Neurology|2021|602
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis
|The Lancet Neurology|2012|512
Novel symptomatology and changing epidemiology of domoic acid toxicosis in California sea lions ( <i>Zalophus californianus</i> ): an increasing risk to marine mammal health
|Proceedings of the Royal Society B Biological Sciences|2007|207